Results 91 to 100 of about 27,390 (214)

Could KIM-1 and NGAL levels predict acute kidney injury after paracentesis? – preliminary study

Renal Failure, 2020
Background Kidney dysfunction is a common complication in patients with severe liver cirrhosis. There is a need for discovery and validation of novel biomarkers for earlier AKI detection.
Marta Pietrukaniec, Maciej Migacz, Agnieszka Żak-Gołąb, Magdalena Olszanecka-Glinianowicz, Jerzy Chudek, Jan Duława, Michał Holecki   +6 more
doaj   +1 more source

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 967-978, April 2026.
Diabetes mellitus independently increases the risk of hepatic encephalopathy following TIPS placement in patients with cirrhosis. These findings emphasize the need for careful risk assessment in patients with cirrhosis and portal hypertension complications undergoing TIPS.
Michelle Spaan, Ellen Werner, Willemijn Dijkstra, Nicole E. Erler, Diederik Bijdevaate, Sarwa Darwish Murad, Milan J. Sonneveld, Caroline M. den Hoed, Anne van Eldere, Dave S. Sprengers, Willem‐Pieter Brouwer, Robert J. de Knegt, Harry L. A. Janssen, Kay Pieterman, Sandra Coenen, Raoel Maan, Adriaan J. van der Meer   +16 more
wiley   +1 more source

LAMELAR CORNEAL TRANSPLANTATION IN A DOG FOR SURGICAL TREATMENT OF CORNEA DEEP ULCER WITH DESCEMETOCELE. [PDF]

, 2018
Corneal transplantation is a procedure indicated for surgical treatment of several corneal diseases, requiring replacement of the affected tissues1,2,3,4.
Alexandre, N., Cardoso, K., Guimarães, T., Laranjo, M.   +3 more
core  

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.
In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.
Marco Sanduzzi‐Zamparelli, Ana Matilla, José Luis Lledo, Sergio Muñoz‐Martínez, María Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Mínguez, Neus Llarch, Laura Márquez, Antonio Guerrero, Gemma Iserte, Andrés Castaño‐García, Laura Carrión, Marta Fortuny, Jordi Rimola, Ángeles García‐Criado, Gema Domenech, Ferran Torres, José Rios‐Guillermo, Loreto Boix, Esther Samper, Àngels Kateb, Jordi Bruix, Maria Reig   +24 more
wiley   +1 more source

Isolated foetal ascites. [PDF]

, 2001
The prenatal diagnosis and perinatal outcome of two patients with isolated foetal ascites compatible with chyloperitoneum is described. The foetal ascites resolved spontaneously after delivery with good perinatal outcome in both cases.
Lam, YH, Leung, WC, Tang, MH
core  

Diffusion-Weighted MRI as a Non-Invasive Diagnostic Tool for Ascites Characterization: A Comparative Analysis of Mean and Minimum ADC Values Against the Serum-Ascites Albumin Gradient

Diagnostics
Background/Objectives: This study aimed to evaluate the diagnostic accuracy of Apparent Diffusion Coefficient (ADC) values, derived from Diffusion-Weighted Imaging (DWI), in differentiating benign and malignant ascites.
Abdullah Enes Ataş, Şeyma Ünüvar, Hasan Eryeşil, Naile Kökbudak   +3 more
doaj   +1 more source

Preventing First and Further Decompensation in Advanced Chronic Liver Disease

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Advanced chronic liver disease (ACLD) remains a major cause of global morbidity and mortality. Preventing hepatic decompensation—both the first event and subsequent recurrences—has become a central therapeutic goal to prolong survival. The transition from the compensated phase (cACLD) to the decompensated phase (dACLD) is driven by clinically ...
Leonardo Corrêa Süffert, Bernardo de Faria Moraes, Guilherme Grossi Lopes Cançado   +2 more
wiley   +1 more source

Transjugular Intrahepatic Portosystemic Shunt for the Management of Medically Refractory Chylous Ascites in Cirrhosis: A Single-Institution Retrospective Analysis

Journal of Clinical Interventional Radiology ISVIR
We report our experience with using transjugular intrahepatic portosystemic shunt (TIPS) for the management of chylous ascites in cirrhotic patients. A total of eight patients were included in the final analysis.
Rajesh Sasidharan, Shubham Suryavanshi, Akhil Baby, Cyriac Abby Philips, Tharun Tom Oommen   +4 more
doaj   +1 more source

PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites

Advanced Science, Volume 13, Issue 16, 18 March 2026.
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang, Qian Shen, Yao Lin, Jing Zhu, Xiaolan Zhu, Rui Huang, Yijia Wu, Feiyang Shen, Qian Li, Guopei Zheng, Zhe Zhang, Qian Chu, Junhao Hu, Jianfeng Shen   +13 more
wiley   +1 more source

A Case of Common Iliac Artery Pseudoaneurysm Formation, Rupture, and Rectal Fistula Caused by Escherichia coli

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT When septic shock is combined with acute lower gastrointestinal bleeding, the rupture and bleeding of a common iliac artery pseudoaneurysm caused by Escherichia coli infection should not be missed. Active surgery combined with strict anti‐infection strategies can save lives.
Xiaojie Zhao, Ling Zhang, Aiqin Liu
wiley   +1 more source